| Study | Location | Sample size E/C | Age E/C | Duration E/C (months) | Duration of treatment (weeks) | Main outcomes | Evaluation method | Outcome odds 95% CI; final pain measurement (95%) | ADs of experimental group | FUP (months) |
|
Cao et al., 2005 [20] | China | 30/30 | 63.2/62.5 | 12.5/12.0 | 4 | TER, CR, IR | Verification of the area | 4.50 1.09–18.50 | NR | NR |
| Di 2009 [14] | China | 32/32 | 57.75/56.59 | 44.64/44.16 | 4 | TER, CR, IR | Verification of the area | 8.68 1.00–75.30 | Two patients: contact dermatitis | 1 |
| Fang et al., 2012 [26] | China | 69/63 | 59.5/60.5 | NR | 4 | TER, CR, IR | Verification of the area | 15.71 0.87–284.88 | NR | NR |
| Feng, 2009 [9] | China | 82/82 | NR | NR | 8 | TER, CR, IR | Verification of the area | 12.06 2.71–53.74 | NR | NR |
| Huang et al., 2009 [19] | China | 30/30 | 62 | NR | 4 | TER, CR, IR | Verification of the area; subjective evaluation of a researcher | 5.80 0.63–53.01 | NR | 24 |
| Jia and Li, 2011 [10] | China | 32/30 | 55.7/56.6 | 17.8/17.9 | 4 | TER, CR, IR | Verification of the area | 6.43 1.26–32.83 | NR | NR |
| Jia, 2012 [15] | China | 28/28 | 53.2 | NR | 3 | TER, CR, IR | Verification of the area; subjective evaluation of a researcher | 10.47 0.54–204.32 | None | NR |
| Li and Zhang, 2013 [11] | China | 40/38 | 48.6/46.2 | 10.8/13.2 | 4 | TER, CR, IR | Verification of the area | 3.34 0.33–33.63 | Three patients: ecchymosis | 6 |
| Peng, 2014 [16] | China | 30/30 | 65.9/66.4 | 81.6/82.44 | 4 | TER, CR, IR, VRT | Verification of the area; subjective evaluation of a researcher; PPG | 3.25 0.89–11.90 | None | NR |
| Wang, 2013 [17] | China | 30/30 | 63.23/63 | 126/120 | 4 | TER, CR, IR, VRT, VP | Verification of the area; subjective evaluation of a researcher; PPG | 4.50 1.09–18.50 | None | NR |
| Xu, 2009 [21] | China | 48/42 | 58/57.8 | 9.5/8.4 | 2 | TER, CR, IR | Verification of the area | 2.03 0.45–9.05 | NR | NR |
| Xu, 2012 [22] | China | 30/30 | 52.5 | NR | 4 | TER, CR, IR, pain | Verification of the area | 1.00 0.23–4.43; E 0.62 (1.13); C 2.13 (1.45) | NR | NR |
| Zhang et al., 2007 [23] | China | 60/45 | 66.7/65.9 | 11.3/14.9 | 4 | TER, CR, IR | Verification of the area; subjective evaluation of a researcher; photography | 10.55 2.22–50.02 | NR | NR |
| Zhang et al., 2008 [24] | China | 30/30 | NR | NR | 4 | TER, CR, IR | Verification of the area; subjective evaluation of a researcher | 5.35 0.25–116.31 | NR | NR |
| Zhang et al., 2008 [18] | China | 62/45 | 54.4/52.8 | NR | 6 | TER, CR, IR | Verification of the area; subjective evaluation of a researcher | 2.85 0.88–9.18 | Two patients: contact dermatitis | NR |
| Zhang, 2013 [25] | China | 27/24 | 59.78/60.05 | 6.44/7.24 | 4 | TER, CR, IR, pain | Verification of the area; subjective evaluation of a researcher | 10.71 1.21–94.96; E 1.76 (0.52); C 1.84 (0.49) | NR | NR |
|
|
RCTs, randomized controlled trials; E, experimental group; C, control group; ADs, adverse events; FUP, follow-up period; NR, no report; TER, total effective rate; CR, curative ratio; IR, inefficiency rate; VRT, venous refill time; PPG, photoplethysmography; VP, venous pressure.
|